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M utations in genes encoding the keratin intermedi-
a te filaments expressed in basal cells have been iden-
tified in some families with epidermolysis bullosa 
simplex as the proximate cause of the fragility. We 
h ave system.atically scanned gen01nic sequences of 
one of these keratins, keratin 14, for mutations in 
patients from 49 apparently independent kindreds 
, s everal years ago three groups independentl y published 
ev idence that mu tatio ns o f the genes encoding kera tins 5 
and 14, the keratins expressed in basa l ke ratinocytes, 
unde rlie the fi:agility of epidermo lysis bullosa simplex 
(EBS), at leas t in some kindreds. Such e vidence included 
localiza tion of the EBS gene by linkage analysis to the sites o f the 
types l and II keratin gene clusters on chrom osom es l 7q and 12q, 
respecti vely, the detectio n o f mutatio ns , and the development o f 
transgeni c m o dels in which the expressio n of mutant keratins 
repro duced th e EBS phenotyp e in mice [1- 4) . T hese studies have 
been foll o w ed by repo rts identifying keratin gene mutation s in four 
othe r hereditary di seases- bullo us congenital ichthyosiform eryth-
rode rma (keratins l and 1 0) [5- 8), palmoplantar epiderm o lytic 
hyperkeratosis (keratin 9) [9 -11 ), ichthyosis bullosa of Siem ens 
(kera tin 2e) [1 2-1. 4], and, most recently, pachyonychia congenita 
(keratins 16 and 17) [1 5]. 
A t this tim e we are aware o f the fo rmal publication of the sites of 
m uta tio ns in keratin s 5 or 14 in 22 appar ently independen t kin-
' dreds- seven in keratin 5 [4,16 -1 9] and 15 in keratin 14 
(1,3 ,17,20 - 26)-and som e mutation-phenotyp e correlations are 
emerging [1 2] . W e have embarked on an effort to extend these 
correlations by identi fyin g mutatio ns in a large number of EBS 
kindreds. W e repo rt here th e results of a scan of the exon and 
flanking intro n sequ ences o f keratin 14 . using sin gle- strand confor-
matio n pol ym o rphism (SSC P) analysis to pinpo int regions ofDNA 
containing po lym orphi c sites . This has allowed the identifi cation o f 
the mu tatio ns in ten new families. 
M ATERI ALS AN D M ETH ODS 
Patients Most affected indi viduals were identifi ed thro ugh the assistance 
of the National EB R egistry or thro ugh D EBRA of America. O thers were 
1 identi fied by de rmato logists who had Jea rnl!d of o ur interest in EBS. T hree 
kindreds fro m Ja pan wert! from Juntcndo Universiry in Tokyo. In total , 49 
apparentl y inde pendent kindreds were idemificd . D N A was extracted from 
peripheral blood le ukocy tes as desc ribed [1]. 
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using single-strand conformation polymorphism 
analysis. The ten mutations identified are clustered at 
three sites-the ends of the helices and the L12 linker 
region, mutation sites that have been identified in past, 
more limited studies. Early onset of blistering in these 
ten families is correlated with more widespread distri-
bution oflesions.J Irwest Dermato/105:629-632, 1995 
Polymerase Chain Rcaction-SSCP Primers were based o n the pub-
lished sequ l!uce of kera tin 14 [27). In each instance EcoRI and Bam HI 
restricti on sites aud a TT or TTTT tai l we re added to the 5 ' ends of the 
u pstream and downstream primers respective ly to fac ilitate subsequen t 
cloniug. T he primers used to am pli fy coding sequences were as fo llo ws 
(base pai r numbering is as pe r [27]): fo r exon I , 
L 12- 31 5' TT GAA TTC TCT CTT CAC TCA GCC TTC TG 3 ', 
L 274-303 5 ' TT GAA TTC GGC T T C AGC AGC AGC AGC AGC 
AGC TIT GGT 3', 
R. 351-334 5' TTTT GGA TCC ACC CAA GCC AGC ACC AAG 3 ' . 
R. 626-607 5' TT GGA T CC GAG CT A GCT GGA ATG GTG CC -3'. 
11... 673-654 5 ' T T GG A TCC GAA AT C TTA AGG T CT C AG CG 3'; 
exon ll. 
L 1766 -1 785 5' TT GAA TTCGCT T AA T GTAGG CTA CAG TG -3' . 
R 2013-1 993 5' TTGGA TCC GTA CTG GCT AGTTCT ATTTGG -3'; 
ex o n II I, 
L 2387-2404 5' TT GAA TTC ACA AGG CAC CAG CTC TGG -3 ' . 
R 2713-2696 5 ' TT GGA TCC TAT GGG CAC GCA CCA CT G -3 ' : 
exon IV. 
L 2896-29 14 5 ' TT GAA TTC TGG GAG GGC ACT ATT CAG G -3' , 
R 3 186-3169 5 ' TTIT GGA TCC CAG AAG GCA GGT GGT CTG -3' : 
cxon V, 
L 3169 - 3 186 5' TTTT GAA T C A GAC CAC CTG CCT TCT G -3'. 
R. 34 19 - 340 1 5 ' TTGGA TCC CG A TTA GTG AGT GT G CCC G -3': 
cxon VI . 
L 3401-34 19 5' TT GAA TTC CGG CCA CAC TCA CTA ATC G -3 ' 
R 3738-3718 5' TTGGA TCCGGA TCA TTA GAT ACA TGG TGG -3'; 
exon VII, 
L 3698-3715 5' TTTT GAA TTC CCA TGG CAC T CT CAC GG -3 ' . 
R 3875- 3857 5' TT GGA T CC AAT CCC TAG ACC TGC TTG G -3'; 
exon V III. 
L 4237- 4256 5 ' TT GAA TIC GGA GTG AAG CAG TAA TCA GG -3'. 
R. 4581-4564 5' TT GGA TCC GGT GAG GGT GAA GCA GGG -3'. 
In a 25-J..tl reaction , 1 00 ng of genomic DN A was ampli fied using 3 I cycles. 
each of 45 seconds at 96°C , 2.0 m in at 55°C, and 2.0 min at 72°C. T he 
buffe r used contained 20 mM (NH 4}oS0.1, 20 mM NaC J, 80 mM T ris, pH 
9, and 2 mM MgCI, . 2.5 picom oles of each primer and 0.75 units ofTaq 
polym erase were used. Both the upstream and th <! downstream primers 
were labeled separately w ith T 4 kinase using an end-labeling kit (Bethesda 
R esearch Laboratories). Amplification products were analyzed by electro-
pho res is o vernight at roo m temperaturl! on M DE-Hydro Link gel (AT 
Biochcm) at 6 wa tt~ per ge l using buf!.c r witho ut glyce rol. T he ge l was dried 
o n fil te r paper and exposed to X-ray fi lm at room temperature overnight 
w ith :1n intensifying screen. 
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Although the prim er pair L 274-303 and R 626-607 gave excellent 
amplification of the 3 ' portion ofexon I, wc could not find a primer pair that 
produced a clean amplification product for the 5' portion of ex on I by direct 
amp li fication of genomic DNA. Therefo re we amplified the whole of cxon 
I u sing the flanking primers L 12-3 1 and R 673-654 and reamplified that 
product with the primers L 12-31 and R 351-334. 
Sequencing Three hundred fifty microliters of polymerase chain reaction 
amplification product with DNA from exons judged by SSCP analysis to 
contain polymorphic sites was purified by m agic polymerase chain reaction 
(Promega), digested with EcoRl and Baml-11, phenol extracted and ethanol 
precipitated, and cloned into pBluescript II (Stratagene). The nucleotide 
sequences of cloned fi:agments w ere determined by the dideoxy-nucleotide 
method using Sequenase (United States Biochemical) using vector primers 
T3 and T7 and, where needed, insert-specific primers. Six to ten clones 
were sequenced at each site studied. 
RESULTS 
We amplified and analyzed by SSCP the intron-exonjunctions and 
exons of keratin 14 of all 49 patients, in each instance analyzing 
separately reactio ns with the upstream or downstream primer 
radiolabeled. Of the 49, 14 consistently had patterns that differed 
from those of the other EBS patients and fi:om those of normal 
contwls. Of the exons with abnormally migrating bands, repeated 
sequencing of multiple clones failed to identify any seq uence 
abnormality in four samples, and in these four samples abnormal 
bands were found after radiolabeling of one, but not the other 
primer. The apparently "false positive" spuriously abnormal SSCP 
results were as follows : three patients, exon VI; one patient, exon 
VIII. Of the remaining ten amplified prod ucts with SSCP-detected 
abnormalities (Fig 1), all had detectable base substitutions (six were 
in ex on I, two were in ex on IV, and two were in exon VI) and all 
were detected irrespective of whether it was the upstream or 
downstream primer that had been radiolabeled. T he detected 
abnormalities are listed in Table I. 
In addition to the above ten missense mutati ons, we identi.fied 
three individuals each of whom had homozygous T ~ C substitu-
tions at both bp 249 in codon 63 and bp 253 in codon 65. These 
substitutions do not change the encoded antino acids (Tyr 63 and 
Leu 65). We also identified several individuals of both European 
and Japanese ancestry of both normal and EBS skin phenotypes 
with a T ~ C substitution at bp 429 in codon 123 . This does not 
change the encoded amino acid (Asn) and has been described 
before as an apparently neutral polymorphism (3,21] . No other 
polymorph isms and none of the above ten mutations were detected 
by SSCP analysis ofexons I, IV, and VI ofDNA from 50 unrelated 
individu als (1 00 alleles) lacking EBS (not shown). 
Of the identifi ed mutation s, one Arg 125 ~ Cys substitution and 
the Gly 120 ~ Arg were in Japanese patients; the other eight 
patients all were of European ancestry. T he abnormal SSCP 
banding patterns of the non-Arg 125 mutations were confirmed to 
be present in all available family members and to be lacking in all 
avai lab le unaffected family members (one to six samples per 
kindred) (Fig 2). Clinical data for the ten fam ilies are summarized 
in Table I. 
DISCUSSION 
These findings increase substantially the number of kindreds with 
EBS in which mut<lti ons have been identified. They are consistent 
with past reports describing clustering of mutations but are derived 
from what to ou r knowledge is the first systemati c survey of the 
complete coding region of keratin 14 in a large number of EBS 
kindreds unselected as to phenotype. Hence they may be more 
representative of the larger popu latio n ofEBS kindreds and suggest 
that previously noted clusterings of mutations was not due to 
sampl e bias (12]. Previous reports plus our f.1i lurc to find mutations 
in exons 11, Ill , V, VII, and Vlll suggest that the regions harborin g 
the majority of keratin 14 mutations ca using EBS have been 
identified-the 1 A and 2B helices and the L12 lin ker seq uences. 
The sites of these mutations have been identified as sites of 
conservation of sequence an1ong type l keratin s and even, in some 
cases , among other intermediate filament proteins as well-the 
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Figure 1. SSCP patterns of DNA an1plilicd from exons I (A and B), 
IV (q, and VI (D). Asterisks mark abnormal bands from affected indi,<id-
ual s in studied kindrcds as follow s. A, l~ji ln11cs 3 n11d -1 , Ta; right ln11es 2--1. 
Yo. B. ln11c 3, .Ja: ln11e 4. Jb. C . ln11c 4, Ma: ln11c 5, R.o: D, ln11e I, Du: /n11c 2. 
W e. All other lanes arc f:icom individuals without EBS. T he normal patterns 
for exon I difFe r in A and B because difrcrent primers were radiolabeled, the 
5' prin1cr in A and the 3' prin1cr in B. 
ini tation region of the 1 A he li x [3 ], and the L12 region [17]. 
Previous reports ha ve been published docum enting pathogenic 
mutation s in type I keratin of heli x lA-residue 4 {keratin 10 (Met 
~ A•·g) L8], keratin 9 (Met ~ Val) [28"1} , and of helix 1 A-residue 
10 {keratin 14 (Arg -'> His [3,23, 29 ] and AJ"g ~ Cys [3,29]); keratin 
10 (Arg ~ His [5-7], Arg ~ Ser (30] , and Arg ~ Pro [30]); and 
ke ra tin 9 (Arg -'> Trp ["I 0,11] and Arg ~ Gin (1 0])}. We have nor 
found published descriptions of mutations of residue 5 of the hel i.:x 
1 A region, in residue 12 of the L12 region , or in residues 72 and 83 
of t h e he li x lB region. Although we have neither statistical.ly 
compelling linkage evidence in any of these families localizing the 
disea se-causing gene to the keratin ·14 region of chrom osome 17q 
nor functional data indica ting that these missense substitution 
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Table I. Detected Abnormalities 
Mutation 131isters 
A!;e of 
Fam ily Region llasepair Codon" Sitc1' Onse t 
Ta 1A 417 Mct 11 11 ,1 ~ lie AO 2 yea rs 
Ja 1A 4"19 Gln 12";-> Arg G 1 week 
Bl l A -133 Arg 12 s 111 ~ Cys G I d 
Jb 1A 433 Arg' 25 " '-> Cys G 3d 
Sc 1A 433 Arg 1" 11, -> Cys G'" 1 d 
Yo 1A 433 Argl 25 1u ~ Scr G 2 d 
Ma Ll 2 3034 Ala 27'11!-> Asp MA'
1 6 months 
Ro L12 3034 Ala27"112 -> Asp G I d 
We 2B 352 1 Ilc377 72 ~ Asn MA 3 months 
Du 2B 3553 Arg"'"\.1 -> Cys AO I yea r 
41 Superscript refers to the position of the amin o ;u.:id in Lhc coding scqm:ncc 127 1: 
subscript refers to the location o f the :nniuo add wirh in dJC domain. i.e .. lA. Ll2. or 
2B [31]. 
,, Site: AO, o1cn:il {hands and/ or feet) on ly; MA. mnstly acra l; G. gcncr:1lizcd. 
r Sc f.1 mil y members also lwvc had ora l erosions. 
d A few bli sters developed on rhc knees of odl.Ccrcd f·:u11il y lllCII Jbcrs during infiuu;y 
afrcr crawling. 
actua ll y inte rfere with intermediate fi lam ent sta bility, our failure to 
detect them in 100 no rmal all e les argues strongly for their patho -
genic role. 
I t is d ifficu lt to make deta il ed corre la tions between the m utation 
site an d the ph enotype, large ly beca use quanti tative estimates of 
disease severity arc lacking. One clinical co rrelation we did find 
was between ea rl y o nset of bliste rs (e.g. , by age I week) and 
genera lized d isease; those with later o n set (e.g., several m o nths to 
2 years o ld) have had blis ters predomi nantly at acra l sites. As has 
been found in oth e r t~Hnilics [3 ,23], patients in o ur kindreds with 
Arg 125 substitutions all had gen e rali zed bli stering. Generalized 
blisterin g also was presen t in thc ja kindred w ith a mutation at G in 
120. Mutations in the first 10 amino ac ids of he lix lA repeatedly 
have been found to be assoc iated with m ore severe disease , and this 
correlates well w ith th e current m odels that indicate this to be an 
importan t region of overl ap betwee11 adjacen t dimcrs and w it h 
experim e ntal studies indi cating that these sequences arc necessary 
1 fo r interaction of model pcptidcs with inta ct keratin polymers f31] . 
Bl Ma 
Sc Ta 
Ro 
L---------------~ 
M 
 
Figure 2 . Pedigrees of families in whom mutations were identified. 
Shaded S)ll /lbols, indi viduals affected with EBS : opcu sy,u/}() /s, unaffected 
persons. Fami ly members whose DNA was assayed by SSC P arc indicated 
by asterisks. 
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Hence th e relative ly mi ld disease (b listers o nly acrally, onset at age 
2 yea rs) in theTa fam ily, in wh ich there .is a Met--'> lle substitution 
at residue 1"19, is anomalous . T lus change does not disrupt the 
hydrophobic characte r of the res idue at this site, and this re lative ly 
"buried " hyd rophobic site predicted to be opposed to t he keratin 5 
partner may ameliorate the eff"ccts of the mutation. Of the five 
amino acids found here to be mutated , all a re among the more 
co mmonl y m u tated amino acids as ranked by general surveys of 
sequen ce databases 132]. 
The ten mutations we detected are conside rably fewe r th an the 
two dozen mutations that we might have predicted would be 
present in the 49 EBS k.indreds , were mutations to be eq ually 
common in EBS patients in ke ratin 14 and in keratin 5, with wh ich 
keratin 14 po lymerizes co form the heterodipolymeric keratin 
in term.ediate fi laments of basal cell s. SSCP is not expected to detect 
all mutations, but one recen t report suggested that its sensitivity 
under various conditions (none of w hich arc exactly those u ti lized 
h ere) is at least 75')1., [33]. Severa l possible explanatio ns other than 
SSCP insensit ive ly for this " low y ie ld" could be su ggested. 
One possibili ty is that EBS could be ca used by mutations in gen es 
e n coding intermediate fi lament-associated proteins such as plectin 
[34,35], IFAP 300 [36] , or th ose en coding proteins impo rtant in 
conn ecting the in term ediate fi lamen t network to the cell m em-
brane o r nuclear m e mbt·an e, e.g .. those of the dcsmosom es . An 
alternative explanation is the poss ibi li ty that EBS in some patients 
could be ca used by ke ratin 5 o r 14 mutations of a type not 
detectable by SSCP an alysis of exons amplified by pt·ime rs hybrid-
iz ing to flanking in tron sites. One recentl y desct;bed exa mple of 
su ch " undetectable" mutations arc those ca using hemophilia A in 
which an intro nic bt·cak that unde rli es 50% of cases was n ot 
detected by genomic scan s such as th at we h ave used [37]. We have 
not bee n ab le to find evide nce favoring su ch abnormalities by 
Southe rn anal ys is of the kerati n 5 and 14 genes of EBS patients 
(C h en et a/, unpublish ed da ta) . A lthough the keratin mu tations 
described so fiu· appea r to encode p roteins that are able to function 
as dominant n egative mutati o ns (i.e . , to disrupt the functio n of the 
protein produced from the normal alle le) [38) , anoth er possibility 
would be that deletion of one alle le would reduce the amount of 
ke ratin 5 or l 4 and thereby weaken the intermediate fil ament 
stru cture . T he lack o f bliste ring ill obligate heterozygotcs in 
k.indreds with autosoma l t·ecessivc EBS, two of which have 
"knock-out" deletions [25,26], wou ld make this explanation a bit 
less likely. Therefore further investigation of EBS patients with 
appa rentl y n orma l keratin 14 seque nces wi ll be needed. 
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